Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.960
-0.060 (-2.97%)
Dec 20, 2024, 4:00 PM EST - Market closed
Alaunos Therapeutics Employees
Alaunos Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 33 or -97.06% compared to the previous year.
Employees
1
Change (1Y)
-33
Growth (1Y)
-97.06%
Revenue / Employee
$7,000
Profits / Employee
-$11,780,000
Market Cap
3.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ReShape Lifesciences | 29 |
InMed Pharmaceuticals | 13 |
Azitra | 10 |
NLS Pharmaceutics AG | 7 |
Artelo Biosciences | 6 |
Titan Pharmaceuticals | 4 |
Tharimmune | 3 |
TCRT News
- 1 year ago - Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Blast Off This Month - Allakos (NASDAQ:ALLK), BioLife Solns (NASDAQ:BLFS) - Benzinga
- 1 year ago - Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics, Inc. (TCRT) Q1 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Alaunos Therapeutics Reports First Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023 - GlobeNewsWire